Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News bioMerieux enters joint venture to create new mircoplate line

bioMerieux enters joint venture to create new mircoplate line

6th February 2008

bioMerieux has entered into a joint venture with Shanghai Kehua Bio-engineering to create a new microplate line..

The Shanghai-based venture will see bioMerieux transferring its microplate immunoassay manufacturing from its current base in the Netherlands over the next two years.

Products resulting from the venture will be distributed in Europe, the Middle East and regions of Asia-Pacific and Latin America.

According to the company, its 60 per cent hold of the capital in the joint venture will help bring together its expertise in immunoassays and infectious disease diagnostics with Kehua’s manufacturing and development capabilities.

Tang Wei Guo, board chairman of Kehua, said: "bioMerieux is a world famous company in the field of diagnostics, with extensive experience and strong global reputation.

"The cooperation will benefit both parties from brand image, sales network and complementary products pipeline."

The two companies are also exploring opportunities for bioMerieux to distribute Kehua’s products through its global network, as part of a longer-term partnership.

bioMerieux is a world leader in the field of in vitro diagnostics, with a presence in more than 150 countries.
ADNFCR-1050-ID-18455904-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.